Product & regulatory approvals
Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.
| Company | Why it’s here — the filing | Reaction 1d / 1w / 1m | Price | Mcap |
|---|---|---|---|---|
| USFDA completes successful inspection at Senores subsidiary Apnar Pharma's Vadodara facility | -3.1% -5.9% — | ₹1,329 | 6,120 Cr | |
| Shilpa Medicare gets SEC nod for OERIS injectable marketing authorization | -3.4% +10.1% — | ₹1,028 | 20,102 Cr | |
| Dealer Network Expansion and GEDA Subsidy Eligibility for EV Products | -1.2% -6.8% — | ₹36.39 | 691 Cr | |
| Acutaas Chemicals gets patent for 2,4-Dimethylthiophenol process, total patents now 11 | -5.6% -5.5% — | ₹3,050 | 24,971 Cr | |
| STL launches plenum-rated fiber trunk assemblies for AI data centers | -0.6% +0.7% — | ₹1,005 | 49,245 Cr | |
| Sigma Advanced Systems starts production at Sri City aerospace facility | +10.3% +25.8% — | ₹1,037 | 18,379 Cr |
Page 2 of 2Previous
How this list is built
A company appears when an NSE/BSE filing inside the last 30 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.
MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.